Literature DB >> 34117382

Clinical electrophysiology of the optic nerve and retinal ganglion cells.

Oliver R Marmoy1,2,3, Suresh Viswanathan4.   

Abstract

Clinical electrophysiological assessment of optic nerve and retinal ganglion cell function can be performed using the Pattern Electroretinogram (PERG), Visual Evoked Potential (VEP) and the Photopic Negative Response (PhNR) amongst other more specialised techniques. In this review, we describe these electrophysiological techniques and their application in diseases affecting the optic nerve and retinal ganglion cells with the exception of glaucoma. The disease groups discussed include hereditary, compressive, toxic/nutritional, traumatic, vascular, inflammatory and intracranial causes for optic nerve or retinal ganglion cell dysfunction. The benefits of objective, electrophysiological measurement of the retinal ganglion cells and optic nerve are discussed, as are their applications in clinical diagnosis of disease, determining prognosis, monitoring progression and response to novel therapies.

Entities:  

Year:  2021        PMID: 34117382     DOI: 10.1038/s41433-021-01614-x

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  193 in total

1.  Flash visual evoked potentials are unreliable as markers of ICP due to high variability in normal subjects.

Authors:  Linnea Andersson; Johanna Sjölund; Josefin Nilsson
Journal:  Acta Neurochir (Wien)       Date:  2011-09-30       Impact factor: 2.216

2.  High test-retest reliability of checkerboard reversal visual evoked potentials (VEP) over 8 months.

Authors:  Johannes Sarnthein; Maria Andersson; Michael B Zimmermann; Dominik Zumsteg
Journal:  Clin Neurophysiol       Date:  2009-09-16       Impact factor: 3.708

3.  The utility of visual evoked potentials using hemifield stimulation and several check sizes in the evaluation of suspected multiple sclerosis.

Authors:  G P Novak; M Wiznitzer; D Kurtzberg; B S Giesser; H G Vaughan
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1988 Jan-Feb

4.  The variation of the pattern shift visual evoked response with the size of the stimulus field.

Authors:  C Yiannikas; J C Walsh
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1983-04

5.  Pattern-reversal visual evoked potentials and retinal eccentricity.

Authors:  J T Meredith; G G Celesia
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1982-03

Review 6.  Evoked potential techniques in the evaluation of visual function.

Authors:  G G Celesia
Journal:  J Clin Neurophysiol       Date:  1984-01       Impact factor: 2.177

7.  Reproducibility of the visual evoked potential using a light-emitting diode stimulator.

Authors:  N F Skuse; D Burke; B McKeon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-06       Impact factor: 10.154

8.  Visual evoked potentials by different check sizes in patients with multiple sclerosis.

Authors:  M Oishi; T Yamada; Q S Dickins; J Kimura
Journal:  Neurology       Date:  1985-10       Impact factor: 9.910

9.  Usefulness of different stimuli in visual evoked potentials.

Authors:  J R Hughes; J L Stone; J J Fino; L A Hart
Journal:  Neurology       Date:  1987-04       Impact factor: 9.910

10.  The changing shape of the ISCEV standard pattern onset VEP.

Authors:  Dorothy A Thompson; Dennis M Fritsch; Sharon E Hardy
Journal:  Doc Ophthalmol       Date:  2017-06-13       Impact factor: 2.379

View more
  3 in total

1.  Morphological and Functional Assessment of the Optic Nerve Head and Retinal Ganglion Cells in Dry vs Chronically Treated Wet Age-Related Macular Degeneration.

Authors:  Małgorzata Wichrowska; Przemysław Wichrowski; Jarosław Kocięcki
Journal:  Clin Ophthalmol       Date:  2022-07-28

2.  The Protective Effects of n-Butylidenephthalide on Retinal Ganglion Cells during Ischemic Injury.

Authors:  Yu-Yau Chou; Jia-Ying Chien; Jhih-Wei Ciou; Shun-Ping Huang
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

3.  Functional and Morphological Changes in the Visual Pathway in Patients with Graves' Orbitopathy.

Authors:  Agnieszka Jagiełło-Korzeniowska; Agata Bałdys-Waligórska; Alicja Hubalewska-Dydejczyk; Bożena Romanowska-Dixon
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.